Welcome to LookChem.com Sign In|Join Free
  • or
19-Hydroxydeoxycorticosterone 21-acetate is a synthetic derivative of the naturally occurring steroid hormone deoxycorticosterone. 19-HYDROXYDEOXYCORTICOSTERONE*21-ACETATE is characterized by the addition of a hydroxyl group at the 19th carbon position and an acetate group at the 21st carbon position. It is used in scientific research to study the effects and mechanisms of steroid hormones, particularly in the context of their biological activities and interactions within the endocrine system. The acetate group in 19-HYDROXYDEOXYCORTICOSTERONE*21-ACETATE can influence its solubility and metabolic properties, making it a valuable tool for investigating the role of steroid hormones in various physiological processes.

6901-40-2

Post Buying Request

6901-40-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6901-40-2 Usage

Chemical compound

A derivative of deoxycorticosterone, a hormone produced by the adrenal glands.

Steroid hormone

Belongs to the class of steroid hormones.

Structural features

Contains a 21-acetate group and a hydroxy group at the 19th carbon position.

Medical applications

Studied for potential use in treating various conditions such as inflammation, hormonal imbalances, and autoimmune diseases.

Diagnostic potential

Being researched as a diagnostic tool for adrenal disorders.

Ongoing research

The precise mechanisms of action and potential therapeutic uses are still under investigation.

Fields of relevance

Shows promise as a valuable tool in the fields of endocrinology and pharmacology.

Check Digit Verification of cas no

The CAS Registry Mumber 6901-40-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,0 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6901-40:
(6*6)+(5*9)+(4*0)+(3*1)+(2*4)+(1*0)=92
92 % 10 = 2
So 6901-40-2 is a valid CAS Registry Number.

6901-40-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 19,21-dihydroxypregn-4-ene-3,20-dione 21-acetate

1.2 Other means of identification

Product number -
Other names 21-acetoxy-19-hydroxypregn-4-ene-3,20-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6901-40-2 SDS

6901-40-2Relevant academic research and scientific papers

Synthesis of 6,19-cyclopregnanes. Constrained analogues of steroid hormones

Di Chenna, Pablo H.,Veleiro, Adriana S.,Sonego, Juan M.,Ceballos, Nora R.,Garland, M. Teresa,Baggio, Ricardo F.,Burton, Gerardo

, p. 2453 - 2457 (2008/02/13)

A procedure for the synthesis of 6,19-cyclopregnanes is described involving an intramolecular alkylation reaction of Δ4-3-keto steroids with a 19-mesylate in the presence of KOH in isopropanol. Three 6,19-cyclopregnanes were prepared (4, 5, 9); in the rat, 6,19-cycloprogesterone (4) and its 21-hydroxy derivative 5 displaced [3H]-dexamethasone from glucocorticoid receptors, the former compound being more active. Both compounds did not compete with [3H]-aldosterone for kidney mineralocorticoid receptors nor with [3H]-R5020 for uterus progesterone receptors. This journal is The Royal Society of Chemistry.

Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids

-

, (2008/06/13)

The present invention is related to novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues, their use as antiglucocorticoids for the treatment and/or prophylaxis of diseases associated to an excess of glucocorticoids. In particular, the invention relates to the use of novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues having the formula FORMULAwherein X is S, SO and SO2, and R is either M or OH, for treating Cushing's syndrome, iatrogenic hypercortisolism or depression. Also the present invention is related to methods of preparing the novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues.

New Syntheses of 19,21-Dihydropregn-4-ene-3,20-dione, 21-Hydroxy-19-norpregn-4-ene-3,20-dione, and 11β,19,21-trihydroxypregn-4-ene-3,20-dione

Kirk, David N.,Yeoh, Boon Leng

, p. 2945 - 2952 (2007/10/02)

19,21-Dihydroxypregn-4-ene-3,20-dione has been synthesized from 3β-acetoxypregn-5-en-20-one via the "hypoiodite reaction" , and Henbest acetoxylation at C-21; oxidation of the intermediate 21-monoacetate to 19-oxo derivative and alkaline cleavage gave 21-hydroxy-19-norpregn-4-ene-3,20-dione.A similar synthesis of 11β,19,21-trihydroxypregn-4-ene-3,20-dione from 3β-acetoxypregn-5-ene-11,20-dione proceeded through intermediates with the 11β-hydroxy function protected as its acetate.Unusual features mainly of conformational origin were observed in the presence of the 11β-acetoxy substituent; some were helpful to the synthesis, while others led to undesirable side reactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6901-40-2